1. Home
  2. BVS vs CBLL Comparison

BVS vs CBLL Comparison

Compare BVS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • CBLL
  • Stock Information
  • Founded
  • BVS 2011
  • CBLL 2014
  • Country
  • BVS United States
  • CBLL United States
  • Employees
  • BVS N/A
  • CBLL N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CBLL
  • Sector
  • BVS Health Care
  • CBLL
  • Exchange
  • BVS Nasdaq
  • CBLL Nasdaq
  • Market Cap
  • BVS 448.8M
  • CBLL 433.7M
  • IPO Year
  • BVS 2021
  • CBLL 2024
  • Fundamental
  • Price
  • BVS $6.67
  • CBLL $12.47
  • Analyst Decision
  • BVS Strong Buy
  • CBLL Strong Buy
  • Analyst Count
  • BVS 4
  • CBLL 6
  • Target Price
  • BVS $13.75
  • CBLL $33.00
  • AVG Volume (30 Days)
  • BVS 291.4K
  • CBLL 259.9K
  • Earning Date
  • BVS 11-04-2025
  • CBLL 11-11-2025
  • Dividend Yield
  • BVS N/A
  • CBLL N/A
  • EPS Growth
  • BVS N/A
  • CBLL N/A
  • EPS
  • BVS 0.03
  • CBLL N/A
  • Revenue
  • BVS $564,142,000.00
  • CBLL $77,419,000.00
  • Revenue This Year
  • BVS N/A
  • CBLL $35.46
  • Revenue Next Year
  • BVS $6.88
  • CBLL $28.18
  • P/E Ratio
  • BVS $237.41
  • CBLL N/A
  • Revenue Growth
  • BVS 5.08
  • CBLL 42.16
  • 52 Week Low
  • BVS $5.81
  • CBLL $10.01
  • 52 Week High
  • BVS $14.38
  • CBLL $32.75
  • Technical
  • Relative Strength Index (RSI)
  • BVS 45.07
  • CBLL 52.61
  • Support Level
  • BVS $6.37
  • CBLL $11.57
  • Resistance Level
  • BVS $6.83
  • CBLL $12.94
  • Average True Range (ATR)
  • BVS 0.25
  • CBLL 0.58
  • MACD
  • BVS -0.02
  • CBLL 0.11
  • Stochastic Oscillator
  • BVS 44.63
  • CBLL 71.77

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: